ZAVEDOS

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ZAVEDOS contains one active pharmaceutical ingredient (API):

1 Idarubicin
UNII 5VV3MDU5IE - IDARUBICIN HYDROCHLORIDE

Idarubicin is a DNA intercalating anthracycline which interacts with the enzyme topoisomerase II and has an inhibitory effect on nucleic acid synthesis. Idarubicin has been shown to have a higher potency with respect to daunorubicin and to be an effective agent against murine leukaemia and lymphomas both by i.v. and oral routes.

Read about Idarubicin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZAVEDOS Powder for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZAVEDOS Capsules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01DB06 Idarubicin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 4440Q, 7247K
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522717090058317, 522717090058417
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 23.789-1-06-11
Country: EE Ravimiamet Identifier(s): 1041208, 1041219, 1041220, 1041231, 1656064, 1706701, 1706712, 1706723, 1888128
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60071, 60072
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 001322, 001372, 169185
Country: FR Base de données publique des médicaments Identifier(s): 60692261, 65133315, 65964950, 67551530, 67651178, 67815446, 69164614
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 44547, 44552, 44560, 44563
Country: HK Department of Health Drug Office Identifier(s): 34636
Country: IE Health Products Regulatory Authority Identifier(s): 88223
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8197
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1010616, 1010617
Country: MT Medicines Authority Identifier(s): AA565/58701
Country: NL Z-Index G-Standaard Identifier(s): 13881736
Country: NL Z-Index G-Standaard, PRK Identifier(s): 52507, 52515, 52523
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 6062, 6066
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100072440, 100072456, 100369564
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65096001, W65097001
Country: SG Health Sciences Authority Identifier(s): 06712P, 06713P, 09971P, 09972P, 09973P, 12455P, 12456P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10803211H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699524790225, 8699524790232
Country: ZA Health Products Regulatory Authority Identifier(s): 33/26/0211, 33/26/0212, 33/26/0213, Y/26/16, Y/26/17

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.